B. Riley Securities Reiterates Buy on Cognition Therapeutics, Maintains $5 Price Target

Cognition Therapeutics, Inc. -6.86%

Cognition Therapeutics, Inc.

CGTX

1.90

-6.86%

B. Riley Securities analyst Mayank Mamtani reiterates Cognition Therapeutics (NASDAQ: CGTX) with a Buy and maintains $5 price target.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via